Please provide your email address to receive an email when new articles are posted on . MONTREAL — Spiriva Respimat, as an add-on to inhaled corticosteroids or long-acting beta2 agonists, reduced the ...
The FINANCIAL — Boehringer Ingelheim on September 16 announced that the U.S. Food and Drug Administration (FDA) approved SPIRIVA Respimat (tiotropium bromide) Inhalation Spray for use in the treatment ...
SAN ANTONIO, Texas--(BUSINESS WIRE)--Tiotropium delivered once daily via Respimat™ significantly improved lung function and reduced asthma exacerbations in patients who remain symptomatic despite ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved Spiriva Respimat for the long-term, once-daily treatment of asthma in patients aged 12 years ...
RIDGEFIELD, Conn., September 16, 2015 – Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved SPIRIVA RESPIMAT for the long-term, ...
Boehringer Ingelheim today announced new data from large scale, Phase III studies showing that once-daily tiotropium delivered via the Respimat ® inhaler was effective and well tolerated in patients ...
This approval was based on efficacy and safety data from the Phase 2 and Phase 3 UniTinA-asthma clinical development program. The Food and Drug Administration (FDA) has approved Spiriva Respimat ...
The PrimoTinA-asthma™ studies are a part of Boehringer Ingelheim’s large international phase III clinical programme named UniTinA-asthma®, which was designed to establish the efficacy and safety of ...
Boehringer Ingelheim has announced positive phase 3 clinical trial data for its asthma drug, tiotropium Respimat. The UniTinA-asthmaTM trial programme found that tiotropium delivered once daily via ...
As expected, Boehringer Ingelheim’s chronic obstructive pulmonary disease blockbuster Spiriva has bagged a UK license and is today being launched for the treatment of asthma, becoming the first ...
Respimat from Boehringer Ingelheim is now the first and only inhaler to be awarded the Ease of Use Commendation by the Arthritis Foundation. This award identifies products that make life easier for ...
Verywell Health on MSN
Comparing asthma inhalers: How to choose
Medically reviewed by Daniel More, MD Key Takeaways Asthma inhalers can be for quick relief or long-term control.Rescue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results